Multispecies model of cell lineages and feedback control in solid tumors

Journal of Theoretical Biology

Volumn 304, Issue , 2012, Pages 39-59

  Youssefpour, H ^a   Li, X ^b   Lander, A D ^a,b   Lowengrub, J S ^a,b  

^a University of California at Irvine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Invasiveness; Stem cells; TGF ; Therapy; Wnt

Indexed keywords

GLUCOSE; OXYGEN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

DISEASE TREATMENT; NUTRIENT; POPULATION DISTRIBUTION; POPULATION SIZE; RADIOGRAPHY; SIMULATION; SPATIOTEMPORAL ANALYSIS; TUMOR;

ARTICLE; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELLULAR DISTRIBUTION; FEEDBACK SYSTEM; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTEIN SECRETION; SELF RENEWAL; SOLID TUMOR; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR MODEL; TUMOR REGRESSION; TUMOR VOLUME;

CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; DISEASE PROGRESSION; FEEDBACK, PHYSIOLOGICAL; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 84859511877     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.02.030     Document Type: Article

References (121)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100(7):3983-3988.
2. Alison M.R., Lim S.M., Nicholson L.J. Cancer stem cells: Problems for therapy?. J. Pathol. 2011, 223(2):147-161.
3. Anderson A.R., Quaranta V. Integrative mathematical oncology. Nat. Rev. Cancer 2008, 8(3):227-234.
4. Anido J., Sáez-Borderías A., Gonzàlez-Juncà A., Rodón L., Folch G., Carmona M.A., Prieto-Sánchez R.M, Barba I., Martínez-Sáez E., Prudkin L., Cuartas I., Raventós C., Martínez-Ricarte F., Poca M.A., García-Dorado D., Lahn M.M., Yingling J.M., Rodón J., Sahuquillo J., Baselga J., Seoane.J. TGF-Β receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 2010, 18(6):655-668.
5. Attolini C.S., Michor F. Evolutionary theory of cancer. Ann. N. Y. Acad. Sci. 2009, 1168:23-51.
6. Bailey J.M., Singh P.K., Hollingsworth M.A. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J. Cell Biochem. 2007, 102(4):829-839.
7. Bapat S.A., Mali A.V., Koppikar C.B., Kurrey N.K. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005, 65(8):3025-3029.
8. Bisson I., Prowse D.M. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res. 2009, 19(6):683-697.
9. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3(7):730-737.
10. Bovolenta P., Esteve P., Ruiz J.M., Cisneros E., Lopez-Rios.J. Beyond Wnt inhibition: New functions of secreted frizzled-related proteins in development and disease. J. Cell Sci. 2008, 121:737-746.
11. Brenner D.J., Hlatky L.R., Hanfeldt P.J., Huang Y., Sachs R.K. Radiation Res. 1998, 150(1):83-91.
12. Bullough W.S. Mitotic and functional homeostasis: A speculative review. Cancer Res. 1965, 25(10):1683-1727.
13. Byrne H.M. Dissecting cancer through mathematics: From the cell to the animal model. Nat. Rev. Cancer 2010, 10(3):221-230.
14. Byun T., Karimi M., Marsh J.L., Milovanovic T., Lin F., Holcombe R.F. Expression of secreted Wnt antagonists in gastrointestinal tissues: Potential role in stem cell homeostasis. J. Clin. Pathol. 2005, 58(5):515-519.
15. Cahn J.W., Hilliard J.E. Free energy of a nonuniform system. 1. Interfacial free energy. J. Chem. Phys. 1958, 28(2):258-267.
16. Cha S.W., Tadjuidje E., White J., Wells J., Mayhew C., Wylie C., Heasman J. Wnt11/5a complex formation caused by tyrosine sulfation increases canonical signaling activity. Curr. Biol. 2009, 19(18):1573-1580.
17. Chang H.H., Hemberg M., Barahona M., Ingber D.E., Huang S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008, 453(7194):544-547.
18. Charafe-Jauffret E., Ginestier C., Birnbaum D. Breast cancer stem cells: Tools and models to rely on. BMC Cancer 2009, 9:202.
19. Choi H., Chun Y.-S., Kim T.Y., Park.J.-W. HIF-2a enhances Β-catenin/TCF-driven transcription by interacting with Β-catenin. Cancer Res. 2010, 70:10101-10111.
20. Chou C.-S., Lo W.-C., Gokoffski K.K., Zhang Y.-T., Wan F.W., Lander A.D., Calof A.L., Nie Q. Spatial dynamics of multistage cell lineages in tissue stratification. Biophysj 2010, 99(10):3145-3154.
21. Clayton E., Doupé D.P., Klein A.M., Winton D.J., Simons B.D., Jones.P.H. A single type of progenitor cell maintains normal epidermis. Nature 2007, 446(7132):185-189.
22. Collins A.T. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65(23):10946-10951.
23. Cristini V., Lowengrub J. Multiscale Modeling of Cancer 2010, Cambridge University Press, New York, NY. 1st ed.
24. Cristini V., Lowengrub J., Nie Q. Nonlinear simulation of tumor growth. J. Math. Biol. 2003, 46(3):191-224.
25. Dale R.G. The application of the linear-quadratic does-effect equation to fractionated and protracted radiotherapy. Br. J. Radiol. 1985, 58:515-528.
26. D'Onofrio A., Tomlinson I.P. A nonlinear mathematical model of cell turnover, differentiation and tumorigenesis in the intestinal crypt. J. Theor. Biol. 2007, 244(3):367-374.
27. Dontu G., Jackson K.W., McNicholas E., Kawamura M.J., Abdallah W.M., Wicha M.S. Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004, 6(6):R605-R615.
28. Douglas B.G., Fowler J.F. Fractionation schedules and a quadratic dose-effect relationship. Br. J. Radiol. 1975, 48(570):502-504.
29. Edelman L.B., Eddy J.A., Price N.D. In silico models of cancer. Wiley Interdiscip Rev. Syst. Biol. Med. 2010, 2(4):438-459.
30. Enderling H., Anderson A.R.A., Chaplain M.A.J., Beheshti A., Hlatky L., Hahnfeldt P. Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Res. 2009, 69(22):8814-8821.
31. Enderling H., Park D., Hlatky L., Hahnfeldt.P. The importance of spatial distribution of stemness and proliferation state in determining tumor radioresponse. Math. Model. Nat. Phenom. 2009, 4(3):117-133.
32. Enderling H., Hlatky L., Hahnfeldt P. Migration rules: Tumours are conglomerates of self-metastases. Br J. Cancer 2009, 100(12):1917-1925.
33. Enderling H., Hlatky L., Hahnfeldt P. Tumor morphological evolution: Directed migration and gain and loss of the self-metastatic phenotype. Biol. Direct. 2010, 5:23.
34. Enderling H., Chaplain M.A.J., Hahnfeldt P. Quantitative modeling of tumor dynamics and radiotherapy. Acta. Biotheor. 2010, 58(4):341-353.
35. Fang D. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 2005, 65(20):9328-9337.
36. Frieboes H.B., Chaplain M.A., Thompson A.M., Bearer E.L., Lowengrub J.S., Cristini V. Physical oncology: A bench-to-bedside quantitative and predictive approach. Cancer Res. 2011, 71(2):298-302.
37. Frieboes H.B., Jin F., Chuang Y.-L.L., Wise S.M., Lowengrub J.S., Cristini V. Three-dimensional multispecies nonlinear tumor growth-II: Tumor invasion and angiogenesis. J. Theor. Biol. 2010, 264(4):1254-1278.
38. Frieboes H.B., Zheng X., Sun C.H., Tromberg B., Gatenby R., Cristini.V. An integrated computational/experimental model of tumor invasion. Cancer Res. 2006, 66(3):1597-1604.
39. Fukuda K., Saikawa Y., Ohashi M., Kumagai K., Kitajima M., Okano H., Matsuzaki Y., Kitagawa Y. Tumor initiating potential of side population cells in human gastric cancer. Int. J. Oncol. 2009, 34(5):1201-1207.
40. Furth J., Kahn M.C. The transmission of leukaemia of mice with a single cell. Am. J. Cancer 1937, 31:276-282.
41. Galle J., Hoffmann M., Aust G. From single cells to tissue architecture-a bottom-up approach to modelling the spatio-temporal organisation of complex multi-cellular systems. J. Math. Biol. 2009, 58(1-2):261-283.
42. Ganguly R., Puri I.K. Mathematical model for the cancer stem cell hypothesis. Cell. Prolif. 2006, 39:3-14.
43. Gierer A., Meinhard H. Theory of biological pattern formation. Kybernetik 1972, 12(1):30-39.
44. Gokoffski K.K., Wu H.-H., Beites C.L., Kim J., Kim E.J., Matzuk M.M., Johnson J.E., Lander A.D., Calof A.L. Activin and GDF11 collaborate in feedback control of neuroepithelial stem cell proliferation and fate. Development 2011, 138(19):4131-4142.
45. González-Sancho J.M., Aguilera O., García J.M., Pendás-Franco N., Peña C., Cal S., De Herreros A.G., Bonilla F., Muñoz A. The Wnt antagonist DICKKOPF-1 gene is a downstream target of Β-catenin/TCF and is downregulated in human colon cancer. Oncogene 2005, 24(6):1098-1103.
46. Granero-Porati M.I., Porati A. Temporal organization in a morphogenic field. J. Math. Biol. 1984, 20:153-157.
47. Gregory C.A., Singh H., Perry A.S., Prockop.D.J. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem. 2003, 278(30):28067-28078.
48. Guo Y., Zi X., Koontz Z., Kim A., Xie J., Gorlick R., Holcombe R.F., Hoang.B.H. Blocking Wnt/Lrp5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma saos-2 cells. J. Orthop. Res. 2007, 25:964-971.
49. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
50. Harpold H.L., Alvord E.C., Swanson K.R. The evolution of mathematical modeling of glioma proliferation and invasion. J. Neuropathol. Exp. Neurol. 2007, 66(1):1-9.
51. Hemmati D.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100(25):15178-15183.
52. Heddleston J.M., Li Z., McLendon R.E., Hjelmeland A.B., Rich J.N. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009, 8(20):3274-3284.
53. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem. Cell 2007, 1(3):313-323.
54. Hillen, T., Enderling, H., Hahnfeldt P. A mathematical model of the tumor growth paradox within the cancer stem cell hypothesis. Preprint (2011).
55. Ho M.M., Ng A.V., Lam S., Hung J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007, 67(10):4827-4833.
56. Hwang-Verslues W.W., Kuo W.-H.H., Chang P.-H.H., Pan C.-C.C., Wang H.-H.H., Tsai S.-T.T., Jeng Y.-M.M., Shew J.-Y.Y., Kung J.T., Chen C.-H.C., Lee E.Y., Chang K.-J.J, Lee W.-H.H. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS ONE 2009, 4(12):e8377.
57. Johnston M.D., Edwards C.M., Bodmer W.F., Maini P.K., Chapman S.J. Examples of mathematical modeling: Tales from the crypt. Cell Cycle 2007, 6(17):2106-2112.
58. Johnston M.D., Edwards C.M., Bodmer W.F., Maini P.K., Chapman S.J. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl. Acad. Sci. USA 2007, 104(10):4008-4013.
59. Johnston M.D., Maini P.K., Jonathan Chapman S., Edwards C.M., Bodmer W.F. On the proportion of cancer stem cells in a tumour. J. Theor. Biol. 2010, 266(4):708-711.
60. Jones C.M., Armes N., Smith J.C. Signalling by TGF-Β family members: Short-range effects of Xnr-2 and BMP-4 contrast with long-range effects of activin. Curr. Biol. 1996, 6(11):1468-1475.
61. Jones P.H., Simons B.D., Watt F.M. Sic transit gloria: Farewell to the epidermal committed progenitor cell?. Cell Stem. Cell 2007, 1(4):371-381.
62. Kalani M.Y., Cheshier S.H., Cord B.J., Bababeygy S.R., Vogel H., Weissman I.L., Palmer T.D., Nusse R. Wnt-mediated self-renewal of neural stem/progenitor cells. Proc. Natl. Acad. Sci. USA 2008, 105(44):16970-16975.
63. Katoh M., Katoh M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 2007, 13(14):4042-4045.
64. Kim J.J., Tannock I.F. Repopulation of cancer cells during therapy: An important cause of treatment failure. Nat. Rev. Cancer 2005, 5(7):516-525.
65. Kirouac D.C., Madlambayan G.J., Yu M., Sykes E.A., Ito C., Zandstra.P.W. Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol. Sys. Biol. 2009, 5(art. number 293).
66. Klaus A., Birchmeier.W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 2008, 8(5):387-398.
67. Kondo S., Kura T. Reaction-diffusion model as a framework for understanding biological pattern formation. Science 2010, 329:1616-1620.
68. Lander A.D., Gokoffski K.K., Wan F.Y., Nie Q., Calof.A.L. Cell lineages and the logic of proliferative control. PLoS Biol. 2009, 7(1):e15.
69. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick.J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367(6464):645-648.
70. Lee N., Smolarz A.J., Olson S., David O., Reiser J., Kutner R., Daw N.C., Prockop D.J., Horwitz E.M., Gregory C.A. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies. Br. J. Cancer 2007, 97(11):1552-1559.
71. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F, Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67(3):1030-1037.
72. Li J., Zhou B.P. Activation of beta-catenin and akt pathways by twist are critical for the maintenance of emt associated cancer stem cell-like characters. BMC Cancer 2011, vol 11:49.
73. Lie D.-C., Colamarino S.A., Song H.-J., Désiré L., Mira H., Consiglio A., Lein E.S., Jessberger S., Lansford H., Dearie A.R., Gage F.H. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437(7063):1370-1375.
74. Lo W.-C., Chou C.-S., Gokoffski K.K., Wan F.Y., Lander A.D., Calof A.L., Nie Q. Feedback regulation in multistage cell lineages. Math. Biosci. Eng. 2009, 6(1):59-82.
75. Loeffler M., Roeder I. Tissue stem cells: Definition, plasticity, heterogeneity, self-organization and models-a conceptual approach. Cells Tissues Organs 2002, 171(1):8-26.
76. Lowengrub J.S., Frieboes H.B., Jin F., Chuang Y.-L.L., Li X., Macklin P., Wise S.W., Cristini.V. Nonlinear modelling of cancer: Bridging the gap between cells and tumours. Nonlinearity 2010, 23(1):R1-R91.
77. Ma S., Chan K.-W.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., Zheng B.-J.J., Guan X.-Y.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132(7):2542-2556.
78. Marciniak-Czochra A., Stiehl T., Ho A.D., Jaeger W., Wagner W. Modeling of asymmetric cell division in hematopoietic stem cells-Regulation of self-renewal is essential for efficient repopulation. Stem Cells Devel. 2009, v. 18(3):377-385.
79. 2 regulates stem cells through Wnt/Β-catenin signaling. Nat. Cell Biol. 2010, 12(10):1007-1015.
80. McPherron A.C., Lawler A.M., Lee S.L. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387(6628):83-90.
81. Meulmeester E., Ten Dijke P. The dynamic roles of TGF-Β in cancer. J. Pathol. 2011, 223(2):205-218.
82. Michor F. Mathematical models of cancer stem cells. J. Clin. Oncol. 2008, 26(17):2854-2861.
83. Monzani.E., Fachetti F., Galmozzi E., Corsisni E., Benetti A., Cavazzin C., Gritti A., Piccinini A., Porro D., Santinami M., Invernici G., Parati E., Alessandri E., La Porta C.A.M. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential. Eur. J. Cancer 2007, 43(5):935-946.
84. Nadji R., Holcombe R.F., Waterman.M.L. Wnt signaling and colon carcinogenesis: Beyond APC. J. Carcinog. 2011, 10:5.
85. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25(57):7469-7481.
86. O'Brien C.A., Pollett A., Gallinger S., Dick.J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445(7123):106-110.
87. Olempska M., Eisenach P.A., Ammerpohl O., Ungefroren H., Fandrich F., Kalthoff H. Detection of tumor stem cell marker in the pancreatic carcinoma cell lines. Hepatobiliary Pancreat. Dis. Int. 2007, 6(1):92-97.
88. Pajonk F., Vlashi E., McBride W.H. Radiation resistance of cancer stem cells: The 4R's of radiobiology revisited. Stem Cells 2010, 28(4):639-648.
89. Pannuti A., Foreman K., Rizzo P., Osipo C., Golde T., Osborne B., Miele.L. Targeting notch to target cancer stem cells. Clin. Cancer Res. 2010, 16(12):3141-3152.
90. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361.
91. Powathil G., Kohandel M., Sivaloganathan S., Oza A., Milosevic M. Mathematical modeling of brain tumors: Effects of radiotherapy and chemotherapy. Phys. Med. Biol. 2007, 52:3291-3306.
92. Preziosi L., Tosin A. Multiphase and multiscale trends in cancer modeling. Math. Model. Nat. Phenom. 2009, 4:1-11.
93. Qiao L., Xu Z.-L.L., Zhao T.-J.J., Ye L.-H.H., Zhang.X.-D.D. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett. 2008, 269(1):67-77.
94. Rejniak K.A., Anderson A.R. Hybrid models of tumor growth. Wiley Interdiscip. Rev. Syst. Biol. Med. 2011, 3(1):115-125.
95. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445(7123):111-115.
96. Rockne R., Rockhill J.K., Mrugala M., Spence A.M., Kalet I., Hendrickson K., Lai A., Cloughesy T., Alvord E.C., Swanson K.R. Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: A mathematical modeling approach. Phys. Med. Biol. 2010, 55:3271-3285.
97. Roose T., Chapman S.J., Maini P.K. Mathematical models of avascular tumor growth. SIAM Rev. 2007, 49(2):179-208.
98. Salazar K.D., Lankford S.M., Brody A.R. Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 297(5):L1002-L1011.
99. Schneider U., Sumila M., Robotka J., Gruber G., Mack A., Besserer J. Does-response relationship for breast cancer induction at radiotherapy dose. Radiat. Oncol. 2011, 6:67.
100. Shafee N., Smith C.R., Wei S., Kim Y., Mills G.B., Hortobagyi G.N., Stanbridge E.J., Lee E.Y.-H.P. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Research 2008, 68(9):3243-3250.
101. Sick S., Reinker S., Timmer J., Schlake.T. WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism. Science 2006, 314:1447-1450.
102. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401.
103. Sottoriva A., Verhoeff J.J., Borovski T., McWeeney S.K., Naumov L., Medema J.P., Sloot P.M., Vermeulen L. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res. 2010, 70(1):46-56.
104. Sottoriva A., Sloot P.M., Medema J.P., Vermeulen L. Exploring cancer stem cell niche directed tumor growth. Cell Cycle 2010, 9(8):1472-1477.
105. Takahashi N., Fukushima T., Yorita K., Tanaka H., Chijiiwa K., Kataoka.H. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int. J. Cancer 2010, 126(7):1611-1620.
106. Takaishi S., Okumura T., Tu S., Wang S.S.W., Shibata W., Vigneshwaran R., Gordon S.A.K., Shimada Y., Wang T.C. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27(5):1006-1020.
107. Tracqui P. Biophysical models of tumour growth. Rep. Prog. Phys. 2009, 72(5):056701.
108. Turing A.M. The chemical basis of morphogenesis. Bull. Math. Biol. 1953, 52(1-2):153-197. discussion 119-52, 1990.
109. Turner N., Grose R. Fibroblast growth factor signalling: From development to cancer. Nat. Rev. Cancer 2010, 10(2):116-129.
110. van Leeuwen I.M., Byrne H.M., Jensen O.E., King J.R. Crypt dynamics and colorectal cancer: Advances in mathematical modelling. Cell Prolif. 2006, 39(3):157-181.
111. van Leeuwen I.M., Mirams G.R., Walter A., Fletcher A., Murray P., Osborne J., Varma S., Young S.J., Cooper J., Doyle B., Pitt-Francis J., Momtahan L., Pathmanathan P., Whiteley J.P., Chapman S.J., Gavaghan D.J., Jensen O.E., King J.R., Maini P.K., Waters S.L., Byrne.H.M. An integrative computational model for intestinal tissue renewal. Cell Prolif. 2009, 42(5):617-636.
112. van Amerongen R., Nusse R. Towards an integrated view of Wnt signaling in development. Development 2009, 136(19):3205-3214.
113. Vermeulen L., Melo F.D.S.E., Heijden M.V.D., Cameron K., Jong J.H.D., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., Sprick M.R., Kemper K., Richel D.J., Stassi G., Medema J.P. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature 2010, 12(5):468-476.
114. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8(10):755-768.
115. Vlashi E., Kim K., Lagadec C., Donna L.D., Mcdonald J.T., Eghbali M., Sayre J.W., Stefani E., Mcbride W., Pajonk F. In vivo Imaging, tracking, and targeting of cancer stem cells. JNCI J. Natl. Cancer Inst. 2009, 101(5):350-359.
116. Watabe T., Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res. 2009, 19(1):103-115.
117. Wise S.M., Lowengrub J.S., Cristini V. An adaptive multigrid algorithm for simulating solid tumor growth using mixture models. Math. Comput. Model 2011, 53(1-2):1-20.
118. Wise S.M., Lowengrub J.S., Frieboes H.B., Cristini V. Three-dimensional multispecies nonlinear tumor growth-I Model and numerical method. Journal of Theoretical Biology 2008, 253(3):524-543.
119. Wu H.H., Ivkovic S., Murray R.C., Jaramillo S., Lyons K.M., Johnson J.E., Calof A.L. Autoregulation of neurogenesis by GDF11. Neuron 2003, 37:197-207.
120. Yin S., Li J., Hu C., Chen X., Yao M., Yan M., Jiang G., Ge C., Xie H., Wan D., Yang S., Zheng S., Gu J. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 2007, vol 120(2007):144-1450.
121. Zipori D. The nature of stem cells: State rather than entity. Nat. Rev. Genet 2004, 5(11):873-878.